DK0752425T3 - Peptidligander for den konstante region på immunoglobuliner - Google Patents

Peptidligander for den konstante region på immunoglobuliner

Info

Publication number
DK0752425T3
DK0752425T3 DK96201706T DK96201706T DK0752425T3 DK 0752425 T3 DK0752425 T3 DK 0752425T3 DK 96201706 T DK96201706 T DK 96201706T DK 96201706 T DK96201706 T DK 96201706T DK 0752425 T3 DK0752425 T3 DK 0752425T3
Authority
DK
Denmark
Prior art keywords
immunoglobulins
amino acid
constant region
peptide
peptide ligands
Prior art date
Application number
DK96201706T
Other languages
Danish (da)
English (en)
Inventor
Giorgio Fassina
Antonio Verdoliva
Menotti Ruvo
Original Assignee
Tecnogen Scpa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT95MI001328A external-priority patent/IT1276761B1/it
Priority claimed from IT96MI000831 external-priority patent/IT1282380B1/it
Application filed by Tecnogen Scpa filed Critical Tecnogen Scpa
Application granted granted Critical
Publication of DK0752425T3 publication Critical patent/DK0752425T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK96201706T 1995-06-21 1996-06-19 Peptidligander for den konstante region på immunoglobuliner DK0752425T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95MI001328A IT1276761B1 (it) 1995-06-21 1995-06-21 Peptidi multimerici
IT96MI000831 IT1282380B1 (it) 1996-04-29 1996-04-29 Peptide utile come ligando

Publications (1)

Publication Number Publication Date
DK0752425T3 true DK0752425T3 (da) 2000-04-10

Family

ID=26331293

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96201706T DK0752425T3 (da) 1995-06-21 1996-06-19 Peptidligander for den konstante region på immunoglobuliner

Country Status (9)

Country Link
US (3) US5880259A (fr)
EP (1) EP0752425B1 (fr)
JP (1) JP3811524B2 (fr)
CN (1) CN1183155C (fr)
AT (1) ATE185147T1 (fr)
CA (1) CA2179562C (fr)
DE (1) DE69604454T2 (fr)
DK (1) DK0752425T3 (fr)
ES (1) ES2137620T3 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE185147T1 (de) 1995-06-21 1999-10-15 Tecnogen Scpa Peptidliganden für die konstante region von immunoglobulinen
ITMI962628A1 (it) * 1996-12-16 1998-06-16 Tecnogen Scpa Composizione farmaceutica
WO1998042392A1 (fr) * 1997-03-25 1998-10-01 Kaneka Corporation Adsorbant destine a eliminer le virus de l'hepatite c, adsorbeur et methode d'adsorption
US6680376B2 (en) * 2000-12-08 2004-01-20 Good Biotech Corporation Process for selectively isolating avian immunoglobulins
US6957672B2 (en) * 2001-07-25 2005-10-25 Imperial Chemical Industries Plc Method for ensuring that coating compositions have correct color
WO2005113604A2 (fr) * 2004-05-14 2005-12-01 Hematech, Llc Procedes de purification d'immunoglobuline
US7651647B1 (en) 2004-07-15 2010-01-26 Pacesetter, Inc. Method for producing highly conductive battery electrodes
ITMI20041569A1 (it) 2004-07-30 2004-10-30 Tecnogen Scpa "ligandi peptidici specifici per le immunoglobuline"
US7408030B2 (en) * 2005-01-13 2008-08-05 North Carolina State University Purification of immunoglobulins using affinity chromatography and peptide ligands
ITMI20071119A1 (it) 2007-06-01 2008-12-02 Tecnogen Spa Nuovi ligandi sintetici per immunoglobuline e composizioni farmaceutiche che li comprendono
EP3465206B1 (fr) 2016-06-06 2019-12-04 Medizinische Universität Wien Procédé pour la détection d'un anticorps igm spécifique d'un flavivirus dans un échantillon
CN106279715A (zh) * 2016-08-30 2017-01-04 武汉大学 一种铜‑肽多孔配位聚合物及其制备方法和应用
CN114585434A (zh) * 2019-10-23 2022-06-03 新加坡国立大学 用于合成化合物的方法和系统

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229490A (en) * 1987-05-06 1993-07-20 The Rockefeller University Multiple antigen peptide system
US5227297A (en) * 1990-04-17 1993-07-13 Smithkline Beecham Corporation Affinity purification ligands
US5141862A (en) * 1990-04-17 1992-08-25 Smithkline Beecham Corporation Method of purifying tpa or plasminogen activator using a tripeptide of the formula: -X-Y-argininal wherein X and Y are selected from the group consisting of pro,phe,trp and tyr
EP0751225B1 (fr) * 1990-10-15 2001-03-28 Tecnogen S.C.P.A. Procédé pour l'identification d'activités protéolytiques et/ou des inhibiteurs de celles-ci
GB9107434D0 (en) * 1991-04-09 1991-05-22 Medical Res Council Peptide-based assay
JPH07188283A (ja) * 1991-04-19 1995-07-25 Suetsuna Yoko 新規なトリペプチドおよびアンジオテンシン変換酵素 阻害剤
US5216126A (en) * 1991-06-19 1993-06-01 Genentech, Inc. Receptor polypeptides and their production and uses
CA2130100A1 (fr) * 1992-03-03 1993-09-16 Ian S. Trowbridge Signaux d'internalisation par recepteurs
WO1995006125A1 (fr) * 1993-08-23 1995-03-02 Applied Immune Sciences, Inc. RECEPTEUR CHIMERIQUE CONTENANT UN DOMAINE DE FIXATION DE L'IgG COMMUN AUX PROTEINES A ET G
ATE185147T1 (de) * 1995-06-21 1999-10-15 Tecnogen Scpa Peptidliganden für die konstante region von immunoglobulinen

Also Published As

Publication number Publication date
CA2179562C (fr) 2007-12-18
DE69604454D1 (de) 1999-11-04
CN1183155C (zh) 2005-01-05
JP3811524B2 (ja) 2006-08-23
US6566077B1 (en) 2003-05-20
EP0752425A3 (fr) 1997-07-09
ATE185147T1 (de) 1999-10-15
CA2179562A1 (fr) 1996-12-22
DE69604454T2 (de) 2000-03-02
EP0752425B1 (fr) 1999-09-29
ES2137620T3 (es) 1999-12-16
JPH0920795A (ja) 1997-01-21
EP0752425A2 (fr) 1997-01-08
CN1145369A (zh) 1997-03-19
US5880259A (en) 1999-03-09
US6207807B1 (en) 2001-03-27

Similar Documents

Publication Publication Date Title
DK0752425T3 (da) Peptidligander for den konstante region på immunoglobuliner
DE69408666D1 (de) Risperidon pamoate
MY137301A (en) Peptide analogs as irreversible interleukin-1b protease inhibitors
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
EP0810209A3 (fr) Sulfamides d'hydroxyéthylamino utiles comme inhibiteurs de protéases rétrovirales
CA2011294A1 (fr) Catalyseur de carbonylage
DK372083D0 (da) Fremgangsmade til fremstilling af peptidderivater, der er inhibitorer overfor proteasesyrer
TR200001740T2 (tr) Mikrobisidal ve bitkiye bağışıklık kazandırıcı aktiviteleri olan tiyazol-türevleri
CA2010035A1 (fr) Derives de proline
ATE171708T1 (de) Flüssigphasensynthese von peptiden und peptidderivaten
ES2001697A6 (es) Procedimiento para preparar 2-aminopurinas sustituidas en posiciones 6 y 9
DE3769910D1 (de) Verwendung von n, n'-bis-l-aminosaeure-l-cystinpeptiden in aminosaeure-praeparaten fuer orale und parenterale ernaehrung.
CA2032303A1 (fr) Inhibiteurs des proteases retrovirales
CA1264899C (fr) Synthese de peptides a l'aide de dioxydes de thioxanthylmethyloxycarbonyle
GB9226144D0 (en) Further improvements relating to the radiolabelling of proteins
DE69715910D1 (de) Pharmazeutische zusammensetzung enthaltend peptide für die inhibierung der immunoglobulin-rezeptor interaktion
ES8206506A1 (es) Procedimiento de preparacion de amino alcosi furanos o tio- fenos.
DE58902254D1 (de) Verfahren zur herstellung von n,n'-bis(3-aminophenyl)harnstoffen.
DE3867039D1 (de) Vincristin enthaltendes produkt.
DE68908958D1 (de) Peptide.
DE69525169D1 (de) Verfahren zur herstellung von n-carboxyanhydridaminosäuren aus n-(n'-nitrosocarbamoyl)-aminosäuren
MX173930B (es) Procedimiento para preparar compuestos de 1h-benzotriazol-hidroxietil -sulfona n1 sustituidos y su empleo para la preparacion de colorantes
RU96118282A (ru) Пептиды для ингибирования высвобождения пепсина
SU1820511A1 (ru) Пептид для защиты животных от вируса ящура a